No Detail Found!

Comparison of Callisphere Drug-Eluting Beads Transarterial Chemoembolization and Conventional Transarterial Chemoembolization for the treatment of Hepatocellular Carcinoma

Author(s)
Yongjun Ren Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province 637000, P.R. China.
Caixia Zhao Department of Oncology, Nanchong Central Hospital, Nanchong, Sichuan Province 637000, P.R. China.
Yongfu Xiong Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province 637000, P.R. China.
Zhongbai Liu Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province 637000, P.R. China.
Guo Wu Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province 637000, P.R. China.
Abstract
Objective: To compare the eficacy of CalliSphere drug-eluting beads (DEBs) and conventional (c) transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Methods: We retrospectively reviewed the clinical data of 125 patients with HCC who had received treatment in Afiliated Hospital of North Sichuan Medical College from January 2018 to February 2019. Sixty-one patients underwent DEB-TACE (observation group) and 64 patients underwent cTACE (control group). The clinical eficacies, overall survivals, and incidence of postoperative adverse reactions between the two groups were compared. Results: The objective response rate in the observation group (85.25%) was higher than that in the control group (70.31%; P<0.05). The disease control in the observation group (96.72%) was higher than that in the control group (85.94%; P<0.05). The median survival time of the observation group (24.85 months) was significantly higher than that in the control group (18.18 months; P<0.05). The incidence of adverse reactions in the observation group (4.92%) was lower than that in the control group (17.19%, P<0.05). Conclusions: In the treatment of HCC, Callisphere DEB-TACE has better eficacy and longer patient survival with fewer adverse reactions compared to cTACE.
Publication Details
Page(s) 303-307
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Hepatocellular carcinoma, Transarterial chemoembolization, Drug-eluting beads transarterial chemoembolization, CalliSpheres, Conventional transarterial chemoembolization
0

Citations

0

Downloads

62

Views